Once again, a new product is launched this week for cancer researchers: RayBio® Cancer Autoantibody Protein Arrays. These arrays are semi-quantitative multiplex protein immunoassays developed for the detection of Cancer related autoantibodies.
The principle is very simple: recombinant proteins are spotted onto a solid glass slide surface, and then probed for the presence of serum specific antibodies to these targets. These detection kits can then be applied in screening specific autoantibodies based on IgA or IgG levels present in patient serum samples.
After these general features, let’s look at the products!
Two arrays are available, each array comes in an 8 sample kit or 16 sample kit format.
- Lung Cancer IgA Autoantibody Array G1 contains 30 human proteins for simultaneous detection of human IgA autoantibodies associated with lung cancer.
- Lung Cancer IgG Autoantibody Array G1 contains 30 human proteins for simultaneous detection of human IgG autoantibodies associated with lung cancer.
Not enough time to use these kits yourself?
Think about outsourcing: these products are available as ready-to-use kits or lab services. To ensure top quality in the data obtained, RayBiotech’s service providers successfully complete training and certification programs to receive the “RayBiotech Certified Array Service Providers” award. In Europe, tebu-bio laboratories (France) were among the first laboratories in the world to be certified by Raybiotech in 2012.
